Open AccessPB2074: IBRUTINIB AS A PROMISING TREATMENT FOR WALDENSTRÖM MACROGLOBULINEMIA
Author(s) -
Ilhan O.,
Cengiz Seval G.,
Avcu F.,
Ferhanoglu B.,
Ozcan M.,
Cetin G.,
Kurtoglu E.,
Yilmaz H.,
Atalay F.,
Gulturk E.,
Nalcaci M.,
Beksac M.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000851128.52895.ec
Subject(s) - ibrutinib , medicine , waldenstrom macroglobulinemia , rituximab , mantle cell lymphoma , oncology , macroglobulinemia , salvage therapy , lymphoplasmacytic lymphoma , progressive disease , chronic lymphocytic leukemia , bruton's tyrosine kinase , lymphoma , chemotherapy , leukemia , tyrosine kinase , multiple myeloma , receptor